In medical communications, I have experience in writing and editing on a wide range of products and devices, including, but not limited to:

• Herceptin (trastuzumab—Roche)

• Bondronat (ibandronate—Roche)

• Mabthera/Rituxan (rituximab—Roche)

• Roferon-A (interferon alfa-2a—Roche)

• Xeloda (capecitabine—Roche)

• Concerta (methylphenidate HCl Extended-release Tablets—McNeil)

• Ambisome (liposomal amphotericin B—Gilead)

• Abilify (aripiprazole—BMS/Otsuka).